FertilAI secures 4.5 million dollars

4.5 million dollars for family planning: FertilAI uses AI to increase the chances of success in fertility medicine - and receives prominent investor support

Tel Aviv, November 20, 2024 - AI-powered platform FertilAI aims to revolutionize the future of fertility medicine with new funding. The startup has raised 4.5 million US dollars in a seed funding round. The round was co-led by Longevity Venture Partners and Redseed, supported by angel investors.

AI solutions for fertility medicine

FertilAI has developed a platform that provides physicians with AI-powered insights into patient data to optimize clinical decisions and improve workflows in fertility clinics. The increased efficiency allows clinics to perform more treatments per day without sacrificing quality.

"The fertility treatment market is growing at a rapid pace and is a globally pressing issue," explains Raissa Hacohen, Managing Partner at Longevity Venture Partners. FertilAI has already shown impressive market traction and offers a solution to the growing need.

In use globally: progress thanks to AI

We are delighted to support FertilAI in further improving clinical outcomes with their innovative algorithms

Helena Cavell, Principal at Redseed

FertilAI's product is used by over 50 physicians worldwide who have already cared for more than 20,000 patients. The Fertilane platform integrates seamlessly with electronic medical records (EMRs) and supports treatment decisions through accurate data analysis. From optimal embryo transfer time to stimulation and ovulation tracking, FertilAI provides tools that improve the treatment process and enhance communication between clinic and patient.

Investment for growth and research

Our goal is to make the process faster and more affordable so that patients don't have to go through multiple expensive rounds of treatment,

Rohi Hourvitz, CEO of FertilAI

The fresh funds will be used for market expansion, staff development and research. FertilAI plans to further develop its solutions for patients and clinics and pave the way to a successful pregnancy for even more families.